BFM
CVS icon

Boothbay Fund Management’s CVS Health CVS Stock Holding History

Boothbay Fund Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.1M Buy
29,296
+24,542
+516% +$1.89M 0.03% 597
2025
Q4 		$377K Buy
+4,754
New +$375K 0.01% 1299
2025
Q3 		– Sell
-5,896
Closed -$407K – 1910
2025
Q2 		$407K Buy
+5,896
New +$387K 0.01% 988
2025
Q1 		– Sell
-6,688
Closed -$300K – 1474
2024
Q4 		$300K Buy
+6,688
New +$375K 0.01% 1070
2024
Q2 		– Sell
-3,213
Closed -$256K – 1589
2024
Q1 		$256K Sell
3,213
-51,037
-94% -$3.9M ﹤0.01% 1255
2023
Q4 		$4.28M Buy
54,250
+22,509
+71% +$1.6M 0.11% 249
2023
Q3 		$2.22M Buy
31,741
+27,936
+734% +$1.98M 0.05% 455
2023
Q2 		$263K Sell
3,805
-2,124
-36% -$151K 0.01% 1362
2023
Q1 		$441K Sell
5,929
-37,172
-86% -$3.12M 0.01% 1305
2022
Q4 		$4.02M Buy
+43,101
New +$4.16M 0.09% 307
2022
Q3 		– Sell
-7,269
Closed -$720K – 2305
2022
Q2 		$674K Buy
7,269
+1,709
+31% +$167K 0.02% 1013
2022
Q1 		$563K Buy
+5,560
New +$584K 0.01% 1231
2019
Q3 		– Sell
-32,917
Closed -$1.79M – 793
2019
Q2 		$1.79M Sell
32,917
-11,288
-26% -$608K 0.16% 164
2019
Q1 		$2.38M Buy
44,205
+41,026
+1,291% +$2.53M 0.23% 99
2018
Q4 		$208K Sell
3,179
-1,396
-31% -$104K 0.03% 483
2018
Q3 		$360K Buy
+4,575
New +$327K 0.04% 457
2017
Q2 		– Sell
-4,580
Closed -$360K – 707
2017
Q1 		$360K Buy
+4,580
New +$366K 0.07% 359
2016
Q4 		– Sell
-2,383
Closed -$212K – 788
2016
Q3 		$212K Sell
2,383
-3,243
-58% -$306K 0.05% 535
2016
Q2 		$539K Buy
+5,626
New +$561K 0.21% 115
2016
Q1 		– Sell
-3,017
Closed -$295K – 371
2015
Q4 		$295K Buy
+3,017
New +$295K 0.13% 272

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boothbay Fund Management's CVS Position: Q1 2026 in Review

Boothbay Fund Management increased its CVS Health (CVS) stake by 516% in Q1 2026, buying an estimated $1.89M and bringing the position to 29,296 shares worth $2.1M. The position accounts for 0.03% of the portfolio, ranked #597.

Boothbay Fund Management first reported a position in CVS in Q4 2015 and has held it in 20 quarters since. The position peaked at $4.28M in Q4 2023. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Boothbay Fund Management held 29,296 shares of CVS Health worth $2.1M as of Q1 2026.
  • Boothbay Fund Management bought 24,542 CVS Health shares in Q1 2026, an estimated $1.89M.
  • CVS Health made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #597 holding.
  • Boothbay Fund Management first reported a position in CVS Health in Q4 2015 and has held it in 20 quarters since.
  • Boothbay Fund Management's CVS Health position peaked at $4.28M in Q4 2023.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.